Scott Tomlins
Scott Tomlins
Associate Professor of Pathology and Urology
Verified email at
Cited by
Cited by
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer
SA Tomlins, DR Rhodes, S Perner, SM Dhanasekaran, R Mehra, XW Sun, ...
science 310 (5748), 644-648, 2005
Integrative clinical genomics of advanced prostate cancer
D Robinson, EM Van Allen, YM Wu, N Schultz, RJ Lonigro, JM Mosquera, ...
Cell 161 (5), 1215-1228, 2015
The mutational landscape of lethal castration-resistant prostate cancer
CS Grasso, YM Wu, DR Robinson, X Cao, SM Dhanasekaran, AP Khan, ...
Nature 487 (7406), 239-243, 2012
The molecular taxonomy of primary prostate cancer
A Abeshouse, J Ahn, R Akbani, A Ally, S Amin, CD Andry, M Annala, ...
Cell 163 (4), 1011-1025, 2015
EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells
CG Kleer, Q Cao, S Varambally, R Shen, I Ota, SA Tomlins, D Ghosh, ...
Proceedings of the national academy of sciences 100 (20), 11606-11611, 2003
Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer
H Beltran, D Prandi, JM Mosquera, M Benelli, L Puca, J Cyrta, C Marotz, ...
Nature medicine 22 (3), 298-305, 2016
Activating ESR1 mutations in hormone-resistant metastatic breast cancer
DR Robinson, YM Wu, P Vats, F Su, RJ Lonigro, X Cao, ...
Nature genetics 45 (12), 1446-1451, 2013
Integrative molecular concept modeling of prostate cancer progression
SA Tomlins, R Mehra, DR Rhodes, X Cao, L Wang, SM Dhanasekaran, ...
Nature genetics 39 (1), 41-51, 2007
An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression
J Yu, J Yu, RS Mani, Q Cao, CJ Brenner, X Cao, X Wang, L Wu, J Li, M Hu, ...
Cancer cell 17 (5), 443-454, 2010
Genomic correlates of clinical outcome in advanced prostate cancer
W Abida, J Cyrta, G Heller, D Prandi, J Armenia, I Coleman, M Cieslik, ...
Proceedings of the National Academy of Sciences 116 (23), 11428-11436, 2019
Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer
SA Tomlins, B Laxman, SM Dhanasekaran, BE Helgeson, X Cao, ...
Nature 448 (7153), 595-599, 2007
Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression
S Varambally, J Yu, B Laxman, DR Rhodes, R Mehra, SA Tomlins, ...
Cancer cell 8 (5), 393-406, 2005
Role of the TMPRSS2-ERG gene fusion in prostate cancer
SA Tomlins, B Laxman, S Varambally, X Cao, J Yu, BE Helgeson, Q Cao, ...
Neoplasia 10 (2), 177-IN9, 2008
Recurrent gene fusions in prostate cancer
C Kumar-Sinha, SA Tomlins, AM Chinnaiyan
Nature Reviews Cancer 8 (7), 497-511, 2008
Integrative clinical genomics of metastatic cancer
DR Robinson, YM Wu, RJ Lonigro, P Vats, E Cobain, J Everett, X Cao, ...
Nature 548 (7667), 297-303, 2017
Identification of targetable FGFR gene fusions in diverse cancers
YM Wu, F Su, S Kalyana-Sundaram, N Khazanov, B Ateeq, X Cao, ...
Cancer discovery 3 (6), 636-647, 2013
TMPRSS2: ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer
S Perner, F Demichelis, R Beroukhim, FH Schmidt, JM Mosquera, S Setlur, ...
Cancer research 66 (17), 8337-8341, 2006
Repression of E-cadherin by the polycomb group protein EZH2 in cancer
Q Cao, J Yu, SM Dhanasekaran, JH Kim, RS Mani, SA Tomlins, R Mehra, ...
Oncogene 27 (58), 7274-7284, 2008
Genomic hallmarks and structural variation in metastatic prostate cancer
DA Quigley, HX Dang, SG Zhao, P Lloyd, R Aggarwal, JJ Alumkal, A Foye, ...
Cell 174 (3), 758-769. e9, 2018
TMPRSS2: ETV4 gene fusions define a third molecular subtype of prostate cancer
SA Tomlins, R Mehra, DR Rhodes, LR Smith, D Roulston, BE Helgeson, ...
Cancer research 66 (7), 3396-3400, 2006
The system can't perform the operation now. Try again later.
Articles 1–20